KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Depreciation & Amortization (CF) (2016 - 2026)

Bristol Myers Squibb has reported Depreciation & Amortization (CF) over the past 18 years, most recently at $594.0 million for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) fell 41.3% to $594.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.6 billion through Mar 2026, down 55.53% year-over-year, with the annual reading at $4.0 billion for FY2025, 58.22% down from the prior year.
  • Depreciation & Amortization (CF) was $594.0 million for Q1 2026 at Bristol Myers Squibb, down from $977.0 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $2.6 billion in Q2 2024 and troughed at $594.0 million in Q1 2026.
  • The 5-year median for Depreciation & Amortization (CF) is $2.4 billion (2023), against an average of $2.0 billion.
  • Year-over-year, Depreciation & Amortization (CF) rose 6.74% in 2024 and then tumbled 61.06% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $2.5 billion in 2022, then decreased by 2.26% to $2.5 billion in 2023, then dropped by 23.7% to $1.9 billion in 2024, then tumbled by 48.03% to $977.0 million in 2025, then plummeted by 39.2% to $594.0 million in 2026.
  • Per Business Quant, the three most recent readings for BMY's Depreciation & Amortization (CF) are $594.0 million (Q1 2026), $977.0 million (Q4 2025), and $1.0 billion (Q3 2025).